Company: LRHC
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112656
Chunk: 209

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 8
Chunk 209
---
 the Redemption Agreement.

On November 12, 2025, following the approval of
the Board of Directors of the Company, the Company and Mr. La Rosa, entered into an Amended and Restated Employment Agreement (the
“Amended Employment Agreement”), which amends and restates that certain Amended and Restated Employment Agreement between
the Company and Mr. La Rosa, dated April 29, 2022, as amended, in its entirety. 

42

ATM
Offering

On November 22, 2024, the Company entered into
a sales agreement (“ATM Agreement”) with A.G.P./Alliance Global Partners, as sales agent, relating to the sale of common stock.
During the three month ended September 30, 2025, the Company issued an aggregate of 75,000 shares of common stock pursuant to the ATM
Agreement for net proceeds of $838,390. The Company paid the sales agent compensation with respect to sale of such shares in the amount
of $25,935. 

Facility and Amended Facility Agreement

On August 4, 2025 (the “Original Agreement
Date”), the Company entered into the Equity Purchase Facility Agreement (“Existing Facility Agreement”) with an institutional
investor (“Facility Investor”), pursuant to which the Facility Investor committed to purchase, subject to certain conditions
and limitations, up to $150,000,000 (the “Commitment Amount”) in newly issued shares of the common stock of the Company (the
“Facility”). In connection with the Facility, on the Original Agreement Date the Company entered into a Registration Rights
Agreement (the “Existing RRA”) with the Facility Investor.

Pursuant to the terms of the Existing Facility
Agreement, the issuance of shares of common stock in excess of 19.99% of the Company’s outstanding shares of common stock was conditional
upon obtaining the approval of the Company’s stockholders in accordance with the rules and regulations of the Nasdaq Capital Market.
On August 6, 2025, the stockholders, holding approximately 96.3% of the votes of our outstanding voting stock approved the Existing Facility
Agreement and Existing RRA, including, but not limited to the issuance of the shares of common stock in excess of 19.99% of the Company’s
issued and outstanding common stock at a price less than the minimum price required by the Nasdaq Capital Market, in compliance with the
rules